Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
70,670,650
-
Share change
-
+8,325,252
-
Total reported value
-
$1,882,039,780
-
Put/Call ratio
-
89%
-
Price per share
-
$26.63
-
Number of holders
-
191
-
Value change
-
+$212,089,646
-
Number of buys
-
96
-
Number of sells
-
87
Institutional Holders of PORTOLA PHARMACEUTICALS INC - COM (PTLA) as of Q3 2018
As of 30 Sep 2018,
PORTOLA PHARMACEUTICALS INC - COM (PTLA) was held by
191 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,670,650 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Vanguard Group Inc, BlackRock Inc., Temasek Holdings (Private) Ltd, Partner Fund Management, L.P., CADIAN CAPITAL MANAGEMENT, LP, STATE STREET CORP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and FMR LLC.
This page lists
191
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.